Background illustration for clinical trials search

Paid Clinical Trials Atlanta

Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

for
Breast Cancer
Location: Atlanta GA, Nashville TN, Chicago IL, Houston TX,
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18+

Code: NCT03990896

Phase 2, Recruiting

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for
Cancer
Location: Atlanta GA, Greenville SC, Charleston SC, Fairfax VA,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT06014658

Phase 1, Phase 2, Recruiting

The PREDICT Registry:

for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Atlanta GA, Nashville TN, Jacksonville FL, Tampa FL,
Sponsor: PreludeDx

Sex: Female

Age: 30 - 70+

Code: NCT03448926

Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Atlanta GA, Nashville TN, Durham NC, Columbus OH,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase 1, Phase 2, Recruiting

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

for
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT05493566

Early Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult,
Location: Atlanta GA, Augusta GA, Nashville TN, Orlando FL,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 19+

Code: NCT06586957

Phase 1, Recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Atlanta GA, Chapel Hill NC, Chicago IL, Milwaukee WI,
Sponsor: Ichnos Sciences SA

Sex: All

Age: 18+

Code: NCT05862012

Phase 1, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Atlanta GA, Augusta GA, Birmingham AL, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase 3, Recruiting

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

for
Ovarian High Grade Serous Adenocarcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT05998135

Phase 2, Recruiting

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

for
IC-MPGN
Location: Atlanta GA, Lancaster SC, Cincinnati OH, St Louis MO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 60

Code: NCT05755386

Phase 3, Recruiting

CAR-T Long Term Follow Up (LTFU) Study

for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Atlanta GA, Nashville TN, Durham NC, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT02445222

Phase 3, Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

for
Leukemia, Myeloid, Chronic, Myeloid Leukemia,
Location: Atlanta GA, Augusta GA, Birmingham AL, Cleveland OH,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04260022

Phase 1, Recruiting

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

for
Borderline Resectable Pancreatic Ductal Adenocarcinoma,
Location: Atlanta GA
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06423326

Phase 2, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Atlanta GA, Birmingham AL, Nashville TN,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase 2, Recruiting

Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

for
Metastatic Malignant Neoplasm in the Brain,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06328686

Early Phase 1, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Atlanta GA, Greenville SC, Birmingham AL, Charleston SC,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase 3, Recruiting

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

for
Prostatic Neoplasms
Location: Atlanta GA, Nashville TN, Charlotte NC, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT06095089

Phase 1, Recruiting

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

for
Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
Location: Atlanta GA, Durham NC, Tampa FL, Columbus OH,
Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT03567889

Phase 3, Recruiting

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

for
Chronic Pancreatitis, Exocrine Pancreas Carcinoma,
Location: Atlanta GA, Cincinnati OH, New Orleans LA,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0 - 17

Code: NCT06651580

Recruiting

A Beta-only IL-2 ImmunoTherapY Study

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Atlanta GA, Boca Raton FL, Detroit MI, Toronto,
Sponsor: Medicenna Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05086692

Phase 1, Phase 2, Recruiting